CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Gilead Sciences, Inc. Company Snapshot
Gilead Sciences, Inc. operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Gilead Sciences with three other pharmaceutical manufacturers in North America: AstraZeneca PLC (2016 sales of $23.00 billion of which 100% was Pharmaceuticals), GlaxoSmithKline plc ($37.50 billion of which 58% was Pharmaceuticals), and Abbvie Inc ($25.64 billion of which 100% was Pharmaceutical Products).

Sales Analysis. Gilead Sciences reported sales of $30.39 billion for the year ending December of 2016. This represents a decrease of 6.9% versus 2015, when the company's sales were $32.64 billion. Contributing to the drop in overall sales was the 8.2% decline in Antiviral Products, from $30.21 billion to $27.75 billion. . However, these declines were partially offset by the increase in sales of Other Products (up 13.6% to $2.21 billion) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Gilead Sciences, Inc.
  Stock Performance Chart for Gilead Sciences, Inc.
 
  Stock Data: Recent Stock Performance:
  Current Price (4/21/2017): 65.93
(Figures in U.S. Dollars)
1 Week -0.9%   13 Weeks -2.3%  
4 Weeks -7.2%   52 Weeks -35.3%  
 
Gilead Sciences, Inc. Key Data:
  Ticker: GILD Country: United States
  Exchanges: NAS FRA MXK Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2016 Sales 30,390,000,000
(Year Ending Jan 2017).
Employees: 5,000
  Currency: U.S. Dollars Market Cap: 86,186,108,181
  Fiscal Yr Ends: December Shares Outstanding: 1,307,236,587
  Share Type: Common Closely Held Shares: 8,156,838
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.